Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-05

FDA Approved: AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved a supplemental application for Strides Pharma Science Limited for a generic fixed-dose combination tablet containing amlodipine besylate, valsartan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE (amlodipine besylate; valsartan; hydrochlorothiazide)

Snippet

SUPPL AP for AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE (AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE)